Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nevada Rx PSE bill dies

This article was originally published in The Tan Sheet

Executive Summary

Nevada state legislators May 22 rejected a proposal to require pseudoephedrine-containing products to be sold only by prescription. The bill, AB 150, did not receive the necessary two-thirds majority to pass. The Consumer Healthcare Products Association lobbied against the bill after its introduction (1"The Tan Sheet" Feb. 26, 2007, In Brief). Currently, Oklahoma and Oregon each have a state law requring prescription-only access to pseudoephedrine products (2"The Tan Sheet" April 12, 2004, p. 4 and 3"The Tan Sheet" Aug. 22, 2005, p. 5)...


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts